Press "Enter" to skip to content

Roche gets European approval for Tecentriq combo vs lung cancer

The combination has been approved as a first-line treatment for people with metastatic non-squamous non-small cell lung cancer (NSCLC).

Original source: https://health.economictimes.indiatimes.com/news/pharma/roche-gets-european-approval-for-tecentriq-combo-vs-lung-cancer/68328209?utm_source=RSS&utm_medium=ETRSS

Also Read:   Cipla Health ventures into Antifungal Product Category with Clocip